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The free radical scavenging activity of Aspalathus linearis (Rooibos tea) and its effect on reactive oxygen
species (ROS), catalase (CAT), and superoxide dismutase (SOD) were investigated in two in vitro disease
models of cancer and diabetes. Although the antioxidant activity of this tea has been reported in several
studies, its effects in disease models of ROS-induced oxidative stress have not been systematically
evaluated to date. The oxygen radical absorbance capacity (ORAC) assay was used in this study to
quantify the antioxidant capacity of the extract, whereas the ROS scavenging ability in hyperglycemia-
induced human umbilical vein endothelial cells (HUVECs) and HeLa cells were investigated. The CAT
and SOD assays were also carried out in the two disease models in order to evaluate the effect of the
extract in the stimulation of these two enzyme activities. The extract was observed to have reduced ROS
in a dose-dependent manner in both HUVECs and HeLa cells. The stimulation of the CAT and SOD enzyme
activities were observed to be dose-dependent as well. The high ORAC value of the extract indicated the
presence of antioxidant compounds which could directly quench ROS, whereby this mechanism of action
could be hypothesized to have been further complemented through the stimulation of CAT and SOD.
Overall, the Aspalathus linearis extract was observed to have increased the CAT and SOD activities in two
in vitro disease models of cancer and hyperglycemia. Given the correlation between the ORAC values, the
increases in CAT and SOD activities and the reduction in ROS in a dose-dependent manner, it could be
hypothesized that the extract had a signiﬁcant therapeutic potential for either the prevention of the
onset of the two diseases or their progression because ROS has been identiﬁed as their root causes.
Copyright © 2014, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. All rights reserved.1. Introduction
Elevation of reactive oxygen species (ROS) such as H2O2, organic
peroxides, and also singlet oxygen has been accepted by many
studies to be the main cause of a wide range of disease conditions
such as diabetes, cardiovascular diseases, and cancer.1 In such cases
of excessive production of ROS, endogenous protectivemechanisms
have been identiﬁed to be insufﬁcient to limit or quench ROS andtudies, Hantane Road, Kandy,
ndara).
for Food and Biomolecules,
molecules, National Taiwan Univetheir subsequent damage inﬂicted especially upon DNA and pro-
teins.2 As additional mechanisms of dietary antioxidants may be of
great importance, many artiﬁcial and natural agents possessing
antioxidant and radical scavenging properties have been proposed
to prevent and to treat oxidative damage induced by ROS-
developed pathological states. Along with a wide scale of artiﬁ-
cially prepared antioxidants, numerous naturally occurring plants
and fruits, containing compounds with antioxidant and radical
scavenging properties have been studied for the purpose of pre-
venting oxidative stress of different etiologies.3,4 This is due to
several advantages they possess, such as low or no toxicity, wide
availability, and a diverse range of medicinal properties which are
able to promote dismutation and trapping of most or all types of
ROS.5,6 Most popular among them are different kinds of herbal teas
widely used as nonalcoholic beverages.6rsity. Production and hosting by Elsevier Taiwan LLC. All rights reserved.
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inal systems for the treatment of infections, ailments, and diseases.
These teas are very often an infusion of dried plant parts steeped in
boiling water. Despite their widespread and established usage in
the East, herbal teas have been gaining popularity in Western
countries in recent years as well.7,8 Hundreds of different herbal
teas are sold in health food stores which are available as pure or
blended samples. Moreover, herbal teas have become a rapidly
popular beverage because of their fragrance and associated thera-
peutic applications.6,9 For instance, tea from Camellia sinensis is the
most widely consumed beverage in the world second only to water,
owing mostly due to its identiﬁcation as an important dietary
source of natural phenolic antioxidants.
Aspalathus linearis (Rooibos tea) is well known for its rich con-
tent of different compounds with antioxidant properties and has
recently gained much attention because of its potential use for
clinical purposes.9,10 Thus, it seems to be of interest to elucidate
whether it is able to initiate its antioxidant properties in disease
models of diabetes and cancer, an aspect which has not been sys-
tematically studied to date. An identiﬁcation of its efﬁcacy against
these diseases would be of value in its promotion as a supple-
mentary therapy. Thus, this study engaged both chemical and
in vitro assays for forming conclusions of its bioactivity against free
radicals produced during these disease conditions. The effect of the
Aspalathus linearis extract against ROS and its inﬂuence on the
enzymatic activity of catalase (CAT) and superoxide dismutase
(SOD) in hyperglycemia-induced human umbilical vein endothelial
cells (HUVECs) and HeLa cells were explored in this study.
2. Materials and methods
Fresh samples of Aspalathus linearis were kindly provided by
Rooibos World Co. (Nagoya, Japan). A voucher specimen of the
sample was deposited in the herbarium of the Temasek School of
Applied Sciences (no. 5242). Dubelcco's modiﬁed eagle's medium
(DMEM), glucose, and antibiotics were purchased from GIBCO (Los
Angeles, USA). Fetal bovine serum (FBS) was purchased from
Hyclone (Utah, USA). HeLa and HUVECs were purchased from
American Type Culture Collection (ATCC, Virginia, USA). Tissue
culture treated T75 ﬂasks, 48-well plates, and 6-well plates were
purchased from CellStar (USA). SOD assay kit was purchased from
Cayman chemicals (Ann Arbor, MI, USA). 5-(and-6)-chloromethyl-
20,70-dichlorodihydroﬂuorescein diacetateacetyl ester (CM-
H2DCFDA) was purchased from Invitrogen (Molecular Probe, New
York, USA). All other reagents were purchased from Sigma Chem-
icals, Singapore unless otherwise stated.
2.1. Preparation of tea extracts
One gram of Aspalathus linearis leaves were extracted with
50 mL boiling water. Infusions were allowed to steep for 1 hour
with continuous swirling. The remnants were ﬁltered and the
extractionwas repeated. The collected extracts were combined and
freeze-dried overnight. The yield of the dried extract as a per-
centage weight of the starting fresh plant material was calculated
as 20.3%. The extracts were powdered and stored at20C until the
various analyses were carried out.
2.2. Determination of the total phenolics content and oxygen
radical absorbance capacity (ORAC) assay
The method, as described by Singleton and Rossi11 was used for
determining the total phenolic content of Aspalathus linearis with
modiﬁcations as suggested by Huang et al12 using the
FolineCiocalteu's phenol reagent. The value was determined usinga standard curve prepared from gallic acid and expressed as mg
gallic acid equivalents/g fresh weight of sample (GAE/g). The ORAC
assay was carried out as described by Huang et al13 in 96-well
microplate format using a Tecan i-control multi well reader using
Inﬁnite 2000 software. Fluorescein disodium was used for the ki-
netic monitoring of free radical quenching and AAPH was used as
the free radical source. The excitation and emission wavelengths
were 485 nm and 528538 nm, respectively. The following compo-
nents were added to a single well: (1) blank (phosphate buffered
saline)/trolox standard/sample 20 mL; (2) ﬂuorescein working so-
lution 160 mL; and (3) AAPH 20 mL. The reaction kinetics were
monitored for 2 hours at 37C, following which the area under the
curvewas used to calculate the ORAC value compared with those of
the trolox standards. Results were expressed as mmol Trolox
Equivalents per gram fresh weight (mmol TE/g) of sample.2.3. Establishment of diabetes and cancer cell models
HUVECs were cultured according to the method by Nishikawa
et al14 whereas HeLa cells were cultured in 2% gelatine-coated
60 mm petri dishes and grown in DMEM low glucose media sup-
plementedwith 20% FBS and 1% antibiotics. HUVECs as well as HeLa
cells were seeded at equal density (12,500 cells per well) in gelatine
coated 48-well plates in its respective media. Both types of cells
were treated with the Aspalathus linearis extracts at concentrations
of 0.1 mg/mL, 0.2 mg/mL, 0.3 mg/mL, 0.4 mg/mL, and 0.5 mg/mL for
5 days based on previous studies on toxicity.15 For HeLa cells,
0.6 mg/mL and 0.7 mg/mL concentrations were also evaluated
based on biochemical evidence from previous studies.16 For the
HUVECs, two control groups of the cells were formed: (1) low
glucose (LG) media (with a glucose concentration of 5.6 mM); and
(2) high glucose (HG) media (with a glucose concentration of
35 mM). Only the HG HUVECs were incubated with the Aspalathus
linearis extracts. It has to be noted that as a comparatively better
experimental approach, both cells were exposed to the oxidative
stress conditions prior to incubation with Aspalathus linearis in
order to mimic the onset of the disease conditions as highlighted in
the study by Nishikawa et al.14 As for the HeLa cells, exposure to
oxidative stress triggering conditions such as H2O2 were not
required due to their existing production of signiﬁcant amounts of
ROS. This production of ROS was further ascertained when a
measurement was carried out using a ﬂuorescent probe as
described in the next paragraph. Several previous studies have also
supported this condition by contrast with other mammalian cells
for the study of ROS production.17e19
CM-H2DCFDA was used to detect the concentration of intracel-
lular ROS. Both HUVECs and HeLa cells were exposed to 20 mL of
20 mM CM-H2DCFDA dissolved in phosphate buffered saline (PBS)
for 45 minutes. Excess CM-H2DCFDA was removed by washing the
cells twice using PBS. The intensity of viable cells was analyzed by
the Tecan i-control multi well reader at 37C using Inﬁnite 2000
software at excitation and emission wavelengths of 492e495 nm
and 517e527 nm, respectively. Five replicates were used per con-
centration of extract for the quantiﬁcation of the ﬂuorescence
intensity.2.4. Evaluation of the CAT and SOD activity
The CAT and SOD enzyme assays were performed in both
HUVECs and HeLa cells according to the protocol provided in the
assay kit by Cayman Chemicals. The results were analyzed by Tecan
i-control multi well reader using Inﬁnite 2000 software at 37C.
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Statistical analyses, which included one-way ANOVA and Tukey
Test, were carried out using SPSS version 10.0 for Windows (SPSS
Inc., IBM, Chicago, IL, USA). Results are expressed as the
mean ± SEM (standard error mean) of ﬁve or more independent
analyses. Values of p < 0.05 were considered to be signiﬁcant.
3. Results
The extract had an ORAC value of 2705 ± 112 mM TE/g. In
comparing with existing antioxidants such as vitamins C (2000 mM
TE/g) and E (1900 mM TE/g),13 this value could be deemed as
signiﬁcantly high. The total phenolics content of the extract was
evaluated as 54.6 ± 4.1 GAE/g. In considering the ratio between the
antioxidant capacity and the total phenolics content, assuming the
antioxidant activity to be coming from only the phenolic com-
pounds of the extract, the measured ORAC value could be consid-
ered as signiﬁcantly high as compared with teas of similar
origin.9,10
For the HUVECs, Aspalathus linearis extracts at 0.5 mg/mL
showed the highest decrease in the ﬂuorescence intensity (Fig. 1A).Fig. 1. (A) Fluorescence intensity of the HUVECs incubated in 30 mM glucose after
treatment with the various concentrations of rooibos tea extracts (mg/mL), 30 mM
glucose without treatment (HG control) and 5.6 mM glucose without treatment (LG
control). (B) Fluorescence intensity of the HeLa cells treated with the various rooibos
tea extracts and untreated with the rooibos tea extracts (untreated control). *p < 0.05
versus the high glucose (HG) control or HeLa cells without any treatment. **p > 0.05
versus the low glucose (LG). HUVECs ¼ human umbilical vein endothelial cells.All concentrations of the extract had statistically signiﬁcant re-
ductions (p < 0.05) in the ﬂuorescence intensities as comparedwith
the HG control. As the ﬂuorescence intensity represents the pres-
ence of ROS, it could be concluded that the extract was able to
successfully reduce the ROS levels in all the hyperglycaemic
HUVECs. It was also noted that the extract concentration of 0.5 mg/
mL did not have a statistically signiﬁcant difference (p < 0.05) as
compared with the LG control indicating the ability of the extract to
reduce the ROS to almost nondiseased physiological concentra-
tions, although whether this is reproducible in actual physiological
conditions requires further exploration. Similar trends were
observed in the extract-treated HeLa cells (Fig. 1B). All concentra-
tions of the extracts had statistically signiﬁcantly (p < 0.05)
decreased the ﬂuorescence intensity in the treated HeLa cells
compared with the untreated control.
The CATand SOD enzyme activities followed comparative trends
to the ROS levels (Fig. 2) indicative of the extract's ability to quench
the ROS via the antioxidant compounds as well as through the
stimulation of the enzyme activity. Both CAT and SOD activities of
the extract-treated HUVECs were statistically signiﬁcantly higher
than the HG control (p < 0.05). The trend in the HeLa cells was
somewhat different to the HUVECs. Despite the constant ROS
concentration of the HeLa cells >0.4 mg/mL of extract, the two
enzyme activities were seen to be increasing proportionately with
the concentrations of the extracts. Nevertheless, all the CAT and
SOD activities of the extract-treated HeLa cells were statistically
signiﬁcantly higher than the untreated control (p < 0.05). Whether
the continuous increases in the CAT and SOD activities in the HeLa
cells along with the increasing concentrations of extracts results in
a physiological beneﬁt in terms of the oxidative stress levels re-
quires further exploration.
4. Discussion
The ORAC assay quantiﬁes the peroxyl radical scavenging ca-
pacity by measuring the ﬂuorescein oxidation. Thus, this assay was
used as an initial screening step to estimate the radical scavenging
ability of the Aspalathus linearis extract. However, because such
chemical assays are unable to characterize the behavior of potential
antioxidants under actual physiological conditions, it has been
recommended to utilize at least two different types of assays
(essentially of chemical and in vitro origin) for the investigation of
antioxidant activities of samples.12,13 In addition, in order to com-
plement the ORAC results as well as to evaluate the potency of the
extract in two disease conditions pertaining to ROS, its effective-
ness was determined in both hyperglycemic HUVECs and HeLa cells
using CM-H2DCFDA. Fluorescent probes have been successfully
used in in vitro studies for the identiﬁcation of the presence of
ROS.14 The oxidation of the probe in the presence of free radicals
results in the increase of the ﬂuorescence intensity. This, in turn,
translates into a signal which can be easily measured using devices
such asmicroplate readers. Through similar methods as used in this
study, an increase in ROS production has been observed in many
studies pertaining to cancer and diabetes hence justifying the usage
of CM-H2DCFDA as a ﬂuorescent probe to measure the presence of
free radicals.20e22
Differing from the HUVECs, the HeLa cells were exposed to
extract concentrations >0.5 mg/mL in this study. This was to
demonstrate that the ROS concentrations did not decrease any
further beyond the concentration of 0.4 mg/mL. Whether the ROS
concentration in the HeLa cells >0.4 mg/mL were reﬂective of a
nondiseased physiological status in this instance is nevertheless
perplexing. However, it was noted that the ﬂuorescence intensity of
the HeLa cells of 0.4 mg/mL were comparable with the ﬂuores-
cence intensity of the HUVECs' LG control. This group could be
Fig. 2. (A) SOD activity and (C) CAT activity of the HUVECs incubated in 30 mM glucose after treatment with the various concentrations of rooibos tea extracts (mg/mL), 30 mM
glucose without treatment (HG control) and 5.6 mM glucose without treatment (LG control); **p > 0.05 versus the high glucose (HG) control. (B) SOD activity and (D) CAT activity of
the HeLa cells treated with the various rooibos tea extracts and untreated with the rooibos tea extracts (untreated control). *p < 0.05 versus the high glucose (HG) control or HeLa
cells without any treatment. CAT ¼ catalase; HG ¼ high glucose; HUVEC ¼ human umbilical vein endothelial cells LG ¼ low glucose; SOD ¼ superoxide dismutase.
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centrations existing in nondiseased conditions. The balance be-
tween oxidation and antioxidation (REDOX status) is known to be
an important factor in maintaining a physiologically healthy bio-
logical milieu. An imbalance in the REDOX status observed in many
of the chronic diseases further conﬁrms the importance of main-
taining the physiological REDOX balance.21,23 In addition, as already
well established, hyperglycemia leads to the excessive production
of ROS, which in turn damages the tertiary structure of the anti-
oxidant enzymes.24e27 It is likely that the radical scavenging ac-
tivity of the herb reduced the denaturation of the antioxidant
enzymes caused by the free radicals. This protective phenomenon
against damage towards antioxidant enzymes has also been
observed in a few other plant extracts.28,29
ROS encompass a variety of diverse chemical species including
superoxide anions, hydroxyl radicals, and hydrogen peroxide. Some
of these species, such as superoxide or hydroxyl radicals, are
extremely unstable, whereas others, such as hydrogen peroxide, are
freely diffusible and relatively long-lived. These various radical
species can either be generated exogenously or produced intra-
cellularly from several different sources. ROS are generally regarded
as a ﬁnal common pathway for cell death and are elicited by all
manner of tissue insults, such as diabetes-induced complications,
ischemia associated with myocardial infarction or stroke, inﬂam-
matory stimuli such as endotoxin, and many anticancer drugs. ROS
are also generated in the mitochondria as part of the multiple
metabolic processes of normal physiology. In susceptible cells, low
levels of oxidants can lead to apoptosis, but high levels can cause
necrotic death. Therapeutic agents acting via cell death and cell
protective pathways are likely to become increasingly prominent in
the next few decades. Prevention of cell death will be of importance
in the prevention of diabetes, stroke, myocardial infarction, andneurodegenerative conditions, whereas highly selective augmen-
tation of cell death will be sought in anticancer drugs. Enhance-
ment of antioxidant defences through dietary supplementation
would seem to provide amore reasonable and practical approach to
reduce the level of oxidative stress and there is awealth of evidence
to support the effectiveness of such a strategy in vitro. The devel-
opment and discovery of novel compounds which behave as mi-
metics of SOD and CAT, or are able to enhance the activity of these
two enzymes has offered an alternative approach with some
promise.30,31
Although this study was able to successfully demonstrate the
antioxidant activity of Rooibos tea in two in vitromodels of diabetes
and cancer, caution must be taken when transferring these results
to in vivo situations. The disease-protective effects of phenolic
compounds may also have adverse prooxidant activities which
have been regularly reported in many studies.32,33 Inconsistencies
between several studies have been raised over the past few years
regarding the association between dietary antioxidants and low
risks of diseases. This could be considered as a reﬂection of the
limitation and complexity of human clinical studies as compared
with in vitro and in vivo evaluations.33,34
5. Conclusion
From these results it can be concluded that Aspalathus linearis,
as a commonly used nonalcoholic beverage, could be an excellent
adjuvant supporting the therapy of diabetes and cancer. From the
ORAC values and antioxidant enzymes data, it may be surmised
that the herbal extract had initiated the antioxidant activities via a
twofold pathway: (1) direct scavenging of free radicals; and (2)
stimulating the expression and activity of CAT and SOD. As a
complete recovery from these disease conditions cannot be
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generally used as supportive therapy in these two diseases as well
as any others where free radicals are involved in their pathological
progression. For this purpose nevertheless, in vitro and/or in vivo
studies, followed by clinical evaluations are essential in order to
obtain a more complete picture of the therapeutic efﬁcacies.
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